These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 1948940

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: long-term follow-up study of 64 patients.
    Manson AJ, Turner K, Lees AJ.
    Mov Disord; 2002 Nov; 17(6):1235-41. PubMed ID: 12465062
    [Abstract] [Full Text] [Related]

  • 5. [Apomorphine for treatment of "off-periods" in Parkinson's disease].
    Zoldan J, Merims D, Kuritzky A, Ziv I, Melamed E.
    Harefuah; 1999 Nov 15; 137(10):444-6, 512, 511. PubMed ID: 10959339
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease.
    Chen JJ, Obering C.
    Clin Ther; 2005 Nov 15; 27(11):1710-24. PubMed ID: 16368444
    [Abstract] [Full Text] [Related]

  • 10. [Apomorphine test in Parkinson disease--dose and corresponding parameters].
    Pinter MM, Helscher RJ, Sattler AP.
    Wien Klin Wochenschr; 1993 Nov 15; 105(16):472-5. PubMed ID: 8212705
    [Abstract] [Full Text] [Related]

  • 11. [Sublingual administration of apomorphine in the treatment of motor fluctuations in Parkinson disease].
    Durif F, Deffond D, Eschalier A, Tournilhac M.
    Rev Neurol (Paris); 1992 Nov 15; 148(10):610-4. PubMed ID: 1295055
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Apomorphine test for dopaminergic responsiveness: a dose assessment study.
    Bonuccelli U, Piccini P, Del Dotto P, Rossi G, Corsini GU, Muratorio A.
    Mov Disord; 1993 Apr 15; 8(2):158-64. PubMed ID: 8474482
    [Abstract] [Full Text] [Related]

  • 15. [Subcutaneous apomorphine in the treatment of Parkinson's disease].
    Linazasoro G.
    Neurologia; 1994 Jan 15; 9(1):1-3. PubMed ID: 8161461
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Continuous subcutaneous apomorphine infusions for fluctuating Parkinson's disease. Long-term follow-up in 18 patients.
    Poewe W, Kleedorfer B, Wagner M, Bösch S, Schelosky L.
    Adv Neurol; 1993 Jan 15; 60():656-9. PubMed ID: 8420206
    [No Abstract] [Full Text] [Related]

  • 19. [Subcutaneous apomorphine infusion in the treatment of Parkinson disease].
    Albani C, Zangger I, Fischer G.
    Schweiz Rundsch Med Prax; 1992 Aug 25; 81(35):1011-5. PubMed ID: 1410978
    [Abstract] [Full Text] [Related]

  • 20. Controlled-release transdermal apomorphine treatment for motor fluctuations in Parkinson's disease.
    Priano L, Albani G, Calderoni S, Baudo S, Lopiano L, Rizzone M, Astolfi V, Cavalli R, Gasco MR, Fraschini F, Bergamasco B, Mauro A.
    Neurol Sci; 2002 Sep 25; 23 Suppl 2():S99-100. PubMed ID: 12548362
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.